Love this...
"The interest in the Company’s development programs and Permetrex™ delivery technology from its recent meetings with potential collaborators at the American Academy of Dermatology meeting in Orlando has been substantial".
A pay day here means potentially no cap raise given the relatively cheap cost of the Acne trials!
Ann: Export and Import Approvals for Clinical Studies Received, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $323.5M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.0¢ | 16.0¢ | $1.594M | 9.684M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 72 | 3839900 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 913601 | 19 |
View Market Depth
| Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
| BOT (ASX) Chart |